Rare diseases
Investigational molecules
Locations
Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options
FranceStudy Comparing Continuous and Fixed Duration Therapy with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Relapsed Multiple Myeloma
FranceStudy on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation
FranceStudy on Ifinatamab Deruxtecan for Patients with Recurrent or Metastatic Solid Tumors
FranceStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
FranceStudy on Encorafenib and Cetuximab for Patients with BRAF V600E-Mutated Localized Colon or Upper Rectum Cancer
FranceStudy on Betamethasone Injection for Pain Relief in Adults with Degenerative Meniscal Injury
FranceStudy on the Safety and Efficacy of Cevostamab with Lenalidomide or Iberdomide for Patients with High-Risk or Relapsed Multiple Myeloma
FranceStudy on Rimegepant for Preventing Migraines in Children and Teens Aged 6 to 17
FranceStudy of Repotrectinib for Frail or Elderly Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Rearrangement
FranceStudy on Post-Operative Chemotherapy with Doxorubicin and Trabectedin for Patients with High-Risk Localized Uterine Leiomyosarcoma
FranceStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
